VOLASTRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Jun 2023)
What this means for you
This application is over — abandoned 19 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88512669
- Mark type
- Stylized text
- Filed
- 12 Jul 2019
- Published for opposition
- 24 Mar 2020
- Abandoned
- 19 Jun 2023
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological, auto-immune and orphan diseases; therapeutic pharmaceutical preparations for the treatment of oncological, auto-immune and orphan diseases
Owner
- Volastra Therapeutics, Inc., New York, NY, US
- Volastra Therapeutics, Inc., New York, NY, US
Prosecution history
- 20 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2022 — SOU EXTENSION 5 GRANTED
- 21 Nov 2022 — SOU EXTENSION 5 FILED
- 02 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 17 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2022 — SOU EXTENSION 4 GRANTED
- 13 May 2022 — SOU EXTENSION 4 FILED
- 13 May 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2021 — SOU EXTENSION 3 GRANTED
- 16 Nov 2021 — SOU EXTENSION 3 FILED
- 16 Nov 2021 — SOU TEAS EXTENSION RECEIVED